Resistance Studies of a Dithiazol Analogue, DBPR110, as a Potential Hepatitis C Virus NS5A Inhibitor in Replicon Systems

Hepatitis C virus (HCV), a member of the Flaviviridae family, affects approximately 3% of the world's population and is becoming the leading cause of liver disease in the world. Therefore, the development of novel or more effective treatment strategies to treat chronic HCV infection is urgently...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lin, Hui-Mei, Wang, Jing-Chyi, Hu, Han-Shu, Wu, Pei-Shan, Wang, Wen-Hung, Wu, Su-Ying, Yang, Chi-Chen, Yeh, Teng-Kuang, Hsu, Tsu-An, Jiaang, Weir-Torn, Chao, Yu-Sheng, Chern, Jyh-Haur, Yueh, Andrew
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2013
Aiheet:
Antiviral Agents
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3553732/
https://ncbi.nlm.nih.gov/pubmed/23165461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01403-12
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia